Menu

Impact Events

More
Date Lead Company Event Type Approval Change Approval Likelihood
9/5/24 Crestone CRS3123 for Clostridium difficile-Associated Diarrhea/Infection (CDAD/CDI) Subscribers Only Subscribers Only Subscribers Only
9/3/24 Athira Pharma (ATHA) ATH-1017 for Alzheimer's Disease (AD) Subscribers Only Subscribers Only Subscribers Only
9/3/24 Praxis (PRAX) Relutrigine for Seizure Disorders (Epilepsy) Subscribers Only Subscribers Only Subscribers Only
9/2/24 Sanofi (SNY) SAR442168 for Multiple Sclerosis (MS) Subscribers Only Subscribers Only Subscribers Only
8/31/24 George Medicines GMRx2 for Hypertension (Systemic) Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

More
Expected Date Range Lead Company Drug Expected Catalyst
01/01/25 - 04/30/24 Subscribers Only Subscribers Only Progress Update - Product Launch
07/31/24 Subscribers Only Subscribers Only Partnership - Acquisition Completion
09/09/24 Subscribers Only Subscribers Only Trial Data - Updated Results
09/09/24 Subscribers Only Subscribers Only Trial Data - Updated Results
09/09/24 Subscribers Only Subscribers Only Trial Data - Updated Results